Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             195 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Ability of SPI2 mutant of S. typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans Khan, S.
2007
25 Supplement 2 p. 4175-4182
8 p.
artikel
2 A combined DNA vaccine enhances protective immunity against Mycobacterium tuberculosis and Brucella abortus in the presence of an IL-12 expression vector Yu, Da-Hai
2007
25 Supplement 2 p. 6744-6754
11 p.
artikel
3 Adjuvant effects of protopanaxadiol and protopanaxatriol saponins from ginseng roots on the immune responses to ovalbumin in mice Sun, Jianhua
2007
25 Supplement 2 p. 1114-1120
7 p.
artikel
4 Administration of hepatitis A vaccine at 6 and 12 months of age concomitantly with hexavalent (DTaP–IPV–PRP∼T–HBs) combination vaccine Stojanov, S.
2007
25 Supplement 2 p. 7549-7558
10 p.
artikel
5 Advances in Immunology and Vaccine Discovery Gay, Cyril G.
2007
25 Supplement 2 p. 7007-7011
5 p.
artikel
6 A fusogenic peptide expressed on the surface of Salmonella enterica elicits CTL responses to a dengue virus epitope Luria-Perez, R.
2007
25 Supplement 2 p. 5071-5085
15 p.
artikel
7 Alphaviral vector-transduced dendritic cells are successful therapeutic vaccines against neu-overexpressing tumors in wild-type mice Moran, Timothy P.
2007
25 Supplement 2 p. 6604-6612
9 p.
artikel
8 Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques Elliott, Matthew B.
2007
25 Supplement 2 p. 7132-7144
13 p.
artikel
9 A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity Carrion Jr., Ricardo
2007
25 Supplement 2 p. 4093-4102
10 p.
artikel
10 Analysis of strategies to successfully vaccinate infants in developing countries against enterotoxigenic E. coli (ETEC) disease Walker, Richard I.
2007
25 Supplement 2 p. 2545-2566
22 p.
artikel
11 A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants Nolan, Terry
2007
25 Supplement 2 p. 8487-8499
13 p.
artikel
12 An overview of the epidemiology of avian influenza Alexander, Dennis J.
2007
25 Supplement 2 p. 5637-5644
8 p.
artikel
13 Antibodies against Kaposi sarcoma-associated herpes virus (KSHV) complement control protein (KCP) in infected individuals Okroj, Marcin
2007
25 Supplement 2 p. 8102-8109
8 p.
artikel
14 Antibody persistence following booster vaccination against tick-borne encephalitis: 3-Year post-booster follow-up Rendi-Wagner, Pamela
2007
25 Supplement 2 p. 5097-5101
5 p.
artikel
15 Antibody responses after dose-sparing intradermal influenza vaccination Auewarakul, Prasert
2007
25 Supplement 2 p. 659-663
5 p.
artikel
16 Antibody response to hepatitis B re-vaccination in HIV-infected children with immune recovery on highly active antiretroviral therapy Lao-araya, Mongkol
2007
25 Supplement 2 p. 5324-5329
6 p.
artikel
17 Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains Tano, Yoshio
2007
25 Supplement 2 p. 7041-7046
6 p.
artikel
18 Antigenic differentiation of classical swine fever vaccinal strain PAV-250 from other strains, including field strains from Mexico Mendoza, Susana
2007
25 Supplement 2 p. 7120-7124
5 p.
artikel
19 A palmitoyl-tailed sequential oligopeptide carrier for engineering immunogenic conjugates Kargakis, Michael
2007
25 Supplement 2 p. 6708-6712
5 p.
artikel
20 A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis Lyons, Arthur
2007
25 Supplement 2 p. 3445-3453
9 p.
artikel
21 A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide—CRM197 with a meningococcal group C conjugate vaccine in healthy infants: Challenge phase Riddell, Anna
2007
25 Supplement 2 p. 3906-3912
7 p.
artikel
22 A recombinant capsid protein from Dengue-2 induces protection in mice against homologous virus Lazo, Laura
2007
25 Supplement 2 p. 1064-1070
7 p.
artikel
23 A recombinant turkey herpesvirus expressing chicken interleukin-2 increases the protection provided by in ovo vaccination with infectious bursal disease and infectious bronchitis virus Tarpey, I.
2007
25 Supplement 2 p. 8529-8535
7 p.
artikel
24 A single DNA immunization in combination with electroporation prolongs the primary immune response and maintains immune memory for six months Tsang, Cemaine
2007
25 Supplement 2 p. 5485-5494
10 p.
artikel
25 Attenuating characteristics of DEN-2 PDK53 in flavivirus-naïve peripheral blood mononuclear cells Rabablert, Jundee
2007
25 Supplement 2 p. 3896-3905
10 p.
artikel
26 Autologous neu DNA vaccine can be as effective as xenogenic neu DNA vaccine by altering administration route Tu, Cheng-Fen
2007
25 Supplement 2 p. 719-728
10 p.
artikel
27 Avian and pandemic influenza: An overview Poland, Gregory A.
2007
25 Supplement 2 p. 3057-3061
5 p.
artikel
28 A Vibrio cholerae serogroup O1 vaccine candidate against CTXETΦ infection Yan, Meiying
2007
25 Supplement 2 p. 4046-4055
10 p.
artikel
29 Cattle immune response to botulinum type D toxoid: Results of a vaccination study Steinman, A.
2007
25 Supplement 2 p. 7636-7640
5 p.
artikel
30 C3d-defined complement receptor-binding peptide p28 conjugated to circumsporozoite protein provides protection against Plasmodium berghei Bergmann-Leitner, Elke S.
2007
25 Supplement 2 p. 7732-7736
5 p.
artikel
31 Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses Kistner, Otfried
2007
25 Supplement 2 p. 6028-6036
9 p.
artikel
32 Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909 Wahid, Rezwanul
2007
25 Supplement 2 p. 1416-1425
10 p.
artikel
33 Central nervous system infection is an important cause of death in underfives hospitalised with World Health Organization (WHO) defined severe and very severe pneumonia Lupisan, Socorro P.
2007
25 Supplement 2 p. 2437-2444
8 p.
artikel
34 Changing epidemiology of invasive pneumococcal disease in central Australia prior to conjugate vaccine: A 16-year study Torzillo, Paul J.
2007
25 Supplement 2 p. 2375-2378
4 p.
artikel
35 Characterization of immunity induced by M2e of influenza virus Wu, Fan
2007
25 Supplement 2 p. 8868-8873
6 p.
artikel
36 Characterization of the MUC1.Tg/MIN transgenic mouse as a model for studying antigen-specific immunotherapy of adenomas Akporiaye, Emmanuel T.
2007
25 Supplement 2 p. 6965-6974
10 p.
artikel
37 Chitosan solution enhances the immunoadjuvant properties of GM-CSF Zaharoff, David A.
2007
25 Supplement 2 p. 8673-8686
14 p.
artikel
38 Community cohort study of Cryptosporidium parvum infections: sex-differential incidences associated with BCG and diptheria–tetanus–pertussis vaccinations Valentiner-Branth, Palle
2007
25 Supplement 2 p. 2733-2741
9 p.
artikel
39 Comparative evaluation of a bivalent killed Salmonella vaccine to prevent egg contamination with Salmonella enterica serovars Enteritidis, Typhimurium, and Gallinarum biovar Pullorum, using 4 different challenge models Okamura, Masashi
2007
25 Supplement 2 p. 4837-4844
8 p.
artikel
40 Comparison of lipopeptide-based immunocontraceptive vaccines containing different lipid groups Chua, Brendon Y.
2007
25 Supplement 2 p. 92-101
10 p.
artikel
41 Comparison of phage pVIII and KLH as vector in inducing the production of cytokines in C57BL/6J mice Su, Quan-ping
2007
25 Supplement 2 p. 970-975
6 p.
artikel
42 Compatibility of plasmids encoding bovine viral diarrhea virus type 1 and type 2 E2 in a single DNA vaccine formulation Liang, Rong
2007
25 Supplement 2 p. 5994-6006
13 p.
artikel
43 Comprehensive epitope analysis of cross-clade Gag-specific T-cell responses in individuals with early HIV-1 infection in the US epidemic Malhotra, Uma
2007
25 Supplement 2 p. 381-390
10 p.
artikel
44 Cross-priming of long lived protective CD8+ T cells against Trypanosoma cruzi infection: Importance of a TLR9 agonist and CD4+ T cells de Alencar, Bruna C.G.
2007
25 Supplement 2 p. 6018-6027
10 p.
artikel
45 Dengue tetravalent DNA vaccine increases its immunogenicity in mice when mixed with a dengue type 2 subunit vaccine or an inactivated Japanese encephalitis vaccine Imoto, Jun-ichi
2007
25 Supplement 2 p. 1076-1084
9 p.
artikel
46 Design and characterization of an HIV-1 Tat mutant: Inactivation of viral and cellular functions but not antigenicity Mayol, Katia
2007
25 Supplement 2 p. 6047-6060
14 p.
artikel
47 Development of a vaccine-challenge model for avian metapneumovirus subtype C in turkeys Velayudhan, Binu T.
2007
25 Supplement 2 p. 1841-1847
7 p.
artikel
48 Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models Okada, Masaji
2007
25 Supplement 2 p. 3038-3040
3 p.
artikel
49 Diphtheria toxoid-containing microparticulate powder formulations for pulmonary vaccination: Preparation, characterization and evaluation in guinea pigs Amidi, Maryam
2007
25 Supplement 2 p. 6818-6829
12 p.
artikel
50 DNA vaccines encoding viral envelope proteins confer protective immunity against WSSV in black tiger shrimp Rout, Namita
2007
25 Supplement 2 p. 2778-2786
9 p.
artikel
51 Does pneumococcal vaccine reduce influenza morbidity in humans? Blay, A.
2007
25 Supplement 2 p. 1071-1075
5 p.
artikel
52 Dose–response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost Liu, Jinyan
2007
25 Supplement 2 p. 2951-2958
8 p.
artikel
53 Editorial Board 2007
25 Supplement 2 p. CO2-
1 p.
artikel
54 Editorial Board 2007
25 Supplement 2 p. CO2-
1 p.
artikel
55 Editorial Board 2007
25 Supplement 2 p. CO2-
1 p.
artikel
56 Editorial Board 2007
25 Supplement 2 p. CO2-
1 p.
artikel
57 Editorial Board 2007
25 Supplement 2 p. CO2-
1 p.
artikel
58 Editorial Board 2007
25 Supplement 2 p. CO2-
1 p.
artikel
59 Effectiveness of Lanzhou lamb rotavirus vaccine against rotavirus gastroenteritis requiring hospitalization: A matched case-control study Fu, Chuanxi
2007
25 Supplement 2 p. 8756-8761
6 p.
artikel
60 Effect of adjuvants and route of immunizations on the immune response to recombinant plague antigens Uddowla, Sabena
2007
25 Supplement 2 p. 7984-7993
10 p.
artikel
61 Effect of immunisation against gonadotrophin releasing hormone isoforms (mammalian GnRH-I, chicken GnRH-II and lamprey GnRH-III) on murine spermatogenesis Khan, Mohammad A.H.
2007
25 Supplement 2 p. 2051-2063
13 p.
artikel
62 Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis Watts, Douglas M.
2007
25 Supplement 2 p. 2913-2918
6 p.
artikel
63 Enhanced antigen delivery via cell death induced by the vaccine adjuvants Yang, Ya-Wun
2007
25 Supplement 2 p. 7763-7772
10 p.
artikel
64 Enhanced protection against Streptococcus pyogenes infection by intranasal vaccination with a dual antigen component M protein/SfbI lipid core peptide vaccine formulation Olive, C.
2007
25 Supplement 2 p. 1789-1797
9 p.
artikel
65 Enhancement of antibody and cellular immune responses to malaria DNA vaccines by in vivo electroporation Dobaño, Carlota
2007
25 Supplement 2 p. 6635-6645
11 p.
artikel
66 Enhancement of immunity to an Escherichia coli vaccine in mice orally inoculated with a fusion gene encoding porcine interleukin 4 and 6 Zhang, Huan
2007
25 Supplement 2 p. 7094-7101
8 p.
artikel
67 Enhancement of intranasal vaccination with recombinant chain A ricin vaccine (rRV) in mice by the mucosal adjuvants LTK63 and LTR72 Kende, Meir
2007
25 Supplement 2 p. 3219-3227
9 p.
artikel
68 Enhancing cancer vaccines with immunomodulators Berinstein, Neil L.
2007
25 Supplement 2 p. B72-B88
nvt p.
artikel
69 Epidemiology of invasive Haemophilus influenzae type b disease in Singapore children, 1994–2003 Thoon, Koh Cheng
2007
25 Supplement 2 p. 6482-6489
8 p.
artikel
70 Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: Results from the 2005–2006 season of dual A and B vaccine mismatch in Canada Skowronski, D.M.
2007
25 Supplement 2 p. 2842-2851
10 p.
artikel
71 Evaluation of antitumor immunity efficacy of epitope-based vaccine with B16 cell line coexpressing HLA-A2/H-2kb and CTL multiepitope in HLA transgenic mice Song, Shuxia
2007
25 Supplement 2 p. 4853-4860
8 p.
artikel
72 Evaluation of combinatorial vaccines against anthrax and plague in a murine model DuBois, Amanda B.
2007
25 Supplement 2 p. 4747-4754
8 p.
artikel
73 Evaluation of neurovirulence and biodistribution of Venezuelan equine encephalitis replicon particles expressing herpes simplex virus type 2 glycoprotein D Kowalski, Jacek
2007
25 Supplement 2 p. 2296-2305
10 p.
artikel
74 Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice Golkar, Majid
2007
25 Supplement 2 p. 4301-4311
11 p.
artikel
75 Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy Rossi, Renato E.
2007
25 Supplement 2 p. 957-964
8 p.
artikel
76 Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies Hu, R.L.
2007
25 Supplement 2 p. 5301-5307
7 p.
artikel
77 Expression library immunization confers partial protection against Chlamydia muridarum genital infection McNeilly, Celia L.
2007
25 Supplement 2 p. 2643-2655
13 p.
artikel
78 Failure of a Mycobacterium tuberculosis ΔRD1 ΔpanCD double deletion mutant in a neonatal calf aerosol M. bovis challenge model: Comparisons to responses elicited by M. bovis bacille Calmette Guerin Waters, W. Ray
2007
25 Supplement 2 p. 7832-7840
9 p.
artikel
79 Fifth International Symposium on Pneumococci and Pneumococcal Diseases, Alice Springs, Central Australia, 2–6 April 2006 Cripps, Allan W.
2007
25 Supplement 2 p. 2361-2365
5 p.
artikel
80 FLK-1-based minigene vaccines induce T cell-mediated suppression of angiogenesis and tumor protective immunity in syngeneic BALB/c mice Luo, Yunping
2007
25 Supplement 2 p. 1409-1415
7 p.
artikel
81 Formulation of the adenylate cyclase toxin of Bordetella pertussis as protein-coated microcrystals Khosravani, Abdolmajid
2007
25 Supplement 2 p. 4361-4367
7 p.
artikel
82 Fusion of antigen to Fas-ligand in a DNA vaccine enhances immunogenicity Nimal, Sonali
2007
25 Supplement 2 p. 2306-2315
10 p.
artikel
83 Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C Gómez, Carmen Elena
2007
25 Supplement 2 p. 1969-1992
24 p.
artikel
84 Generation of long-lived plasma cells to serogroup B Neisseria meningitidis after murine immunisation with an outer membrane protein vaccine Cruz, Simone C.
2007
25 Supplement 2 p. 5046-5052
7 p.
artikel
85 Genetic diversity of pneumococcal surface protein A of Streptococcus pneumoniae meningitis in German children Heeg, Christiane
2007
25 Supplement 2 p. 1030-1035
6 p.
artikel
86 Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection Quan, Fu Shi
2007
25 Supplement 2 p. 272-282
11 p.
artikel
87 Ginsenoside Rd elicits Th1 and Th2 immune responses to ovalbumin in mice Yang, Zhigang
2007
25 Supplement 2 p. 161-169
9 p.
artikel
88 Gonococcal transferrin binding protein chimeras induce bactericidal and growth inhibitory antibodies in mice Price, Gregory A.
2007
25 Supplement 2 p. 7247-7260
14 p.
artikel
89 Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1IIIB Gag-Pol-Nef proteins of clade B Gómez, Carmen Elena
2007
25 Supplement 2 p. 2863-2885
23 p.
artikel
90 Hepatitis A vaccination of Argentinean infants: Comparison of two vaccination schedules López, E.L.
2007
25 Supplement 2 p. 102-108
7 p.
artikel
91 Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies Stamataki, Zania
2007
25 Supplement 2 p. 7773-7784
12 p.
artikel
92 Herd immunity and pneumococcal conjugate vaccine: A quantitative model Haber, Michael
2007
25 Supplement 2 p. 5390-5398
9 p.
artikel
93 Higher pertussis hospitalization rates in indigenous Australian infants, and delayed vaccination Kolos, Veronica
2007
25 Supplement 2 p. 588-590
3 p.
artikel
94 High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture Liu, Chia-Chyi
2007
25 Supplement 2 p. 19-24
6 p.
artikel
95 Human antibody response towards the pneumococcal surface proteins PspA and PspC during invasive pneumococcal infection Linder, Adam
2007
25 Supplement 2 p. 341-345
5 p.
artikel
96 Humoral and cell-mediated immune responses of humans to inactivated influenza vaccine with or without QS21 adjuvant Mbawuike, I.
2007
25 Supplement 2 p. 3263-3269
7 p.
artikel
97 Immune responses of pigs to commercialized emulsion FMD vaccines and live virus challenge Chen, S.P.
2007
25 Supplement 2 p. 4464-4469
6 p.
artikel
98 Immune responses of two recombinant adenoviruses expressing VP1 antigens of FMDV fused with porcine granulocyte macrophage colony-stimulating factor Du, Yijun
2007
25 Supplement 2 p. 8209-8219
11 p.
artikel
99 Immune response to two different dosing schedules of the anthrax vaccine precipitated (AVP) vaccine Hepburn, Matthew J.
2007
25 Supplement 2 p. 6089-6097
9 p.
artikel
100 Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines Craigo, Jodi K.
2007
25 Supplement 2 p. 834-845
12 p.
artikel
101 Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model Singh, Shree R.
2007
25 Supplement 2 p. 6211-6223
13 p.
artikel
102 Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants Ruggeberg, Jens U.
2007
25 Supplement 2 p. 264-271
8 p.
artikel
103 Immunogenicity and safety of a new Vero cell rabies vaccine produced using serum-free medium Costa, Wagner A.
2007
25 Supplement 2 p. 8140-8145
6 p.
artikel
104 Immunogenicity and safety of pneumococcal 7-valent conjugate vaccine (diphtheria CRM197 protein conjugate; Prevenar™) in Korean infants: Differences that are found in Asian children Kim, Nam-Hee
2007
25 Supplement 2 p. 7858-7865
8 p.
artikel
105 Immunogenicity of a combination vaccine containing pneumococcal conjugates and meningococcal PorA OMVs van den Dobbelsteen, Germie P.J.M.
2007
25 Supplement 2 p. 2491-2496
6 p.
artikel
106 Immunoregulatory activity by daucosterol, a β-sitosterol glycoside, induces protective Th1 immune response against disseminated Candidiasis in mice Lee, Jue-Hee
2007
25 Supplement 2 p. 3834-3840
7 p.
artikel
107 Impact of previous immunisation on the incidence of meningococcal disease during an outbreak in a Sahelian area of Senegal Chippaux, J.-P.
2007
25 Supplement 2 p. 1712-1718
7 p.
artikel
108 IMP321 (sLAG-3) safety and T cell response potentiation using an influenza vaccine as a model antigen: A single-blind phase I study Brignone, Chrystelle
2007
25 Supplement 2 p. 4641-4650
10 p.
artikel
109 Increased risk of chronic suppurative lung disease after measles or pertussis in non-vaccinated children Montella, Silvia
2007
25 Supplement 2 p. 402-403
2 p.
artikel
110 Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans Eller, Michael A.
2007
25 Supplement 2 p. 7737-7742
6 p.
artikel
111 Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine Olsson, Sven-Eric
2007
25 Supplement 2 p. 4931-4939
9 p.
artikel
112 Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin Bright, Rick A.
2007
25 Supplement 2 p. 3871-3878
8 p.
artikel
113 Innate antiviral resistance influences the efficacy of a recombinant murine cytomegalovirus immunocontraceptive vaccine Lloyd, Megan L.
2007
25 Supplement 2 p. 679-690
12 p.
artikel
114 Intradermal administration of DNA vaccines combining a strategy to bypass antigen processing with a strategy to prolong dendritic cell survival enhances DNA vaccine potency Huang, Bruce
2007
25 Supplement 2 p. 7824-7831
8 p.
artikel
115 Intranasal immunization with synthetic peptides corresponding to the E6 and E7 oncoproteins of human papillomavirus type 16 induces systemic and mucosal cellular immune responses and tumor protection Manuri, Pallavi R.
2007
25 Supplement 2 p. 3302-3310
9 p.
artikel
116 Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology Cyr, Sonya L.
2007
25 Supplement 2 p. 5378-5389
12 p.
artikel
117 Intravaginal administration of an inactivated vaccine prevents lesions induced by caprine herpesvirus-1 in goats Camero, Michele
2007
25 Supplement 2 p. 1658-1661
4 p.
artikel
118 Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine Asanuma, Hideki
2007
25 Supplement 2 p. 6975-6980
6 p.
artikel
119 Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: Double-blind randomised efficacy field trial Lemesre, Jean-Loup
2007
25 Supplement 2 p. 4223-4234
12 p.
artikel
120 Long-term colonisation–inhibition studies to protect broilers against colonisation with Salmonella Enteritidis, using Salmonella Pathogenicity Island 1 and 2 mutants Bohez, Lotte
2007
25 Supplement 2 p. 4235-4243
9 p.
artikel
121 Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents Gabbuti, Andrea
2007
25 Supplement 2 p. 3129-3132
4 p.
artikel
122 Major CD4 epitopes involved in anti-CD4 T-cell autoimmunity in HIV-1 patients Abulafia-Lapid, Rivka
2007
25 Supplement 2 p. 3192-3199
8 p.
artikel
123 Microbial heat shock protein 70 stimulatory properties have different TLR requirements Qazi, Khaleda Rahman
2007
25 Supplement 2 p. 1096-1103
8 p.
artikel
124 Modulation of the infant immune responses by the first pertussis vaccine administrations Mascart, F.
2007
25 Supplement 2 p. 391-398
8 p.
artikel
125 Monitoring temperatures in the vaccine cold chain in Bolivia Nelson, Carib
2007
25 Supplement 2 p. 433-437
5 p.
artikel
126 Mucosal delivery of a transmission-blocking DNA vaccine encoding Giardia lamblia CWP2 by Salmonella typhimurium bactofection vehicle Abdul-Wahid, Aws
2007
25 Supplement 2 p. 8372-8383
12 p.
artikel
127 Mucosal inoculation with an attenuated mouse pneumovirus strain protects against virulent challenge in wild type and interferon-gamma receptor deficient mice Ellis, John A.
2007
25 Supplement 2 p. 1085-1095
11 p.
artikel
128 Multiple CD4 and CD8 T-cell activation parameters predict vaccine efficacy in vivo mediated by individual DC-activating agonists Welters, Marij J.P.
2007
25 Supplement 2 p. 1379-1389
11 p.
artikel
129 Mutant influenza A virus nucleoprotein is preferentially localized in the cytoplasm and its immunization in mice shows higher immunogenicity and cross-reactivity Ohba, Kenji
2007
25 Supplement 2 p. 4291-4300
10 p.
artikel
130 New meningococcal C polysaccharide-tetanus toxoid conjugate Cuello, Maribel
2007
25 Supplement 2 p. 1798-1805
8 p.
artikel
131 Novel marker vaccines against classical swine fever Beer, Martin
2007
25 Supplement 2 p. 5665-5670
6 p.
artikel
132 Occurrence of severe gastroenteritis in pups after canine parvovirus vaccine administration: A clinical and laboratory diagnostic dilemma Decaro, Nicola
2007
25 Supplement 2 p. 1161-1166
6 p.
artikel
133 Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis KuoLee, Rhonda
2007
25 Supplement 2 p. 3781-3791
11 p.
artikel
134 Oral vaccination of mice with lipid-encapsulated Mycobacterium bovis BCG: Effect of reducing or eliminating BCG load on cell-mediated immunity Cross, M.L.
2007
25 Supplement 2 p. 1297-1303
7 p.
artikel
135 Overcoming the need for a cold chain with conjugated meningococcal Group C vaccine: A controlled, randomized, double-blind study in toddlers on the safety and immunogenicity of Menjugate®, stored at room temperature for 6 months Schöndorf, Ines
2007
25 Supplement 2 p. 1175-1182
8 p.
artikel
136 Pathophysiology of white-tailed deer vaccinated with porcine zona pellucida immunocontraceptive Curtis, Paul D.
2007
25 Supplement 2 p. 4623-4630
8 p.
artikel
137 Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong Ho, Pak-Leung
2007
25 Supplement 2 p. 6837-6841
5 p.
artikel
138 Perspectives on the development of a therapeutic HER-2 cancer vaccine Renard, Valéry
2007
25 Supplement 2 p. B17-B23
nvt p.
artikel
139 Pertussis vaccine and infantile spasms Lapatsanis, Petros
2007
25 Supplement 2 p. 404-405
2 p.
artikel
140 Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants Qadri, Firdausi
2007
25 Supplement 2 p. 231-238
8 p.
artikel
141 Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine Catanzaro, Andrew T.
2007
25 Supplement 2 p. 4085-4092
8 p.
artikel
142 Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research Polhemus, Mark E.
2007
25 Supplement 2 p. 4203-4212
10 p.
artikel
143 Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya Stoute, José A.
2007
25 Supplement 2 p. 176-184
9 p.
artikel
144 Population-based seroprevalence of Neisseria meningitidis serogroup C capsular antibody before the introduction of conjugate vaccine, in Australia Backhouse, J.L.
2007
25 Supplement 2 p. 1310-1315
6 p.
artikel
145 Potential effects of decreased cervical cancer screening participation after HPV vaccination: An example from the U.S. Kulasingam, Shalini L.
2007
25 Supplement 2 p. 8110-8113
4 p.
artikel
146 Prevenar™ vaccination: Review of the global data, 2006 Center, Kimberly J.
2007
25 Supplement 2 p. 3085-3089
5 p.
artikel
147 Prime-boost immunization with DNA followed by a recombinant vaccinia virus expressing P50 induced protective immunity against Babesia gibsoni infection in dogs Fukumoto, Shinya
2007
25 Supplement 2 p. 1334-1341
8 p.
artikel
148 Priming with DNA vaccine and boosting with killed vaccine conferring protection of chickens against infectious bursal disease Hsieh, Ming Kun
2007
25 Supplement 2 p. 5417-5427
11 p.
artikel
149 Private demand for cholera vaccines in Beira, Mozambique Lucas, Marcelino E.S.
2007
25 Supplement 2 p. 2599-2609
11 p.
artikel
150 Production of dengue 2 envelope domain III in plant using TMV-based vector system Saejung, Wanida
2007
25 Supplement 2 p. 6646-6654
9 p.
artikel
151 Pro-inflammatory and antiviral cytokine expression in vaccinated and unvaccinated horses exposed to equine influenza virus Quinlivan, Michelle
2007
25 Supplement 2 p. 7056-7064
9 p.
artikel
152 Protective efficacy of neutralizing antibodies against Ebola virus infection Takada, Ayato
2007
25 Supplement 2 p. 993-999
7 p.
artikel
153 Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: Implications for the Brazilian National Immunization Program 2007
25 Supplement 2 p. 3118-3123
6 p.
artikel
154 Recombinant capripoxviruses expressing proteins of bluetongue virus: Evaluation of immune responses and protection in small ruminants Perrin, Aurélie
2007
25 Supplement 2 p. 6774-6783
10 p.
artikel
155 Recombinant human parainfluenza virus type 2 vaccine candidates containing a 3′ genomic promoter mutation and L polymerase mutations are attenuated and protective in non-human primates Nolan, Sheila M.
2007
25 Supplement 2 p. 6409-6422
14 p.
artikel
156 Recombinant vaccines based on translocated effector proteins of Salmonella Pathogenicity Island 2 Husseiny, Mohamed I.
2007
25 Supplement 2 p. 185-193
9 p.
artikel
157 Relationships among physico-chemical and biological tests for a synthetic Hib–TT conjugate vaccine Cuervo, Mario Landys Chovel
2007
25 Supplement 2 p. 194-200
7 p.
artikel
158 Risk factors for influenza infection in vaccinated racehorses: Lessons from an outbreak in Newmarket, UK in 2003 Barquero, Nuria
2007
25 Supplement 2 p. 7520-7529
10 p.
artikel
159 RLJ-NE-299A: A new plant based vaccine adjuvant Khajuria, Anamika
2007
25 Supplement 2 p. 2706-2715
10 p.
artikel
160 Role of T lymphocyte replicative senescence in vaccine efficacy Effros, Rita B.
2007
25 Supplement 2 p. 599-604
6 p.
artikel
161 Rotavirus disease in Uzbekistan: Cost-effectiveness of a new vaccine Isakbaeva, E.T.
2007
25 Supplement 2 p. 373-380
8 p.
artikel
162 Safety and immunogenicity of a zoster vaccine in varicella-zoster virus seronegative and low-seropositive healthy adults Macaladad, N.
2007
25 Supplement 2 p. 2139-2144
6 p.
artikel
163 Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults Kshirsagar, Nilima
2007
25 Supplement 2 p. A101-A107
nvt p.
artikel
164 Safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated polio vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine Partridge, Susan
2007
25 Supplement 2 p. 1806-1813
8 p.
artikel
165 Safety of a trivalent meningococcal ACW135 vaccine among young children in Ethiopia Aseffa, Abraham
2007
25 Supplement 2 p. A79-A82
nvt p.
artikel
166 Safety of DTaP–IPV–HIb–HBV hexavalent vaccine in very premature infants Faldella, Giacomo
2007
25 Supplement 2 p. 1036-1042
7 p.
artikel
167 Serotype distribution and antimicrobial susceptibility of S. pneumoniae causing invasive disease in Thai children younger than 5 years old, 2000–2005 Phongsamart, Wanatpreeya
2007
25 Supplement 2 p. 1275-1280
6 p.
artikel
168 Short-term response to a booster dose of hepatitis B vaccine in anti-HBs negative adolescents who had received primary vaccination 16 years ago Wang, Li-Yu
2007
25 Supplement 2 p. 7160-7167
8 p.
artikel
169 Shuffling of pig interleukin-2 gene and its enhancing of immunity in mice to Pasteurella multocida vaccine Xie, Zhao
2007
25 Supplement 2 p. 8163-8171
9 p.
artikel
170 Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: A case–control study in Nepalese children 5 years after immunization Tandan, J.B.
2007
25 Supplement 2 p. 5041-5045
5 p.
artikel
171 Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: Effects of dosage and route on safety and immunogenicity Peters, Barry S.
2007
25 Supplement 2 p. 2120-2127
8 p.
artikel
172 Survey of poliovirus antibodies during the final stage of polio eradication in Egypt El-Sayed, Nasr
2007
25 Supplement 2 p. 5062-5070
9 p.
artikel
173 Synthetic vaccine update: Applying lessons learned from recent SPf66 malarial vaccine physicochemical, structural and immunological characterization Bermúdez, Adriana
2007
25 Supplement 2 p. 4487-4501
15 p.
artikel
174 The antigenicity of a Plasmodium vivax reticulocyte binding protein-1 (PvRBP1) recombinant fragment in humans and its immunogenicity and protection studies in Aotus monkeys Rojas Caraballo, Jose
2007
25 Supplement 2 p. 3713-3721
9 p.
artikel
175 The combination of GM-CSF and IL-2 as local adjuvant shows synergy in enhancing peptide vaccines and provides long term tumor protection Toubaji, Antoun
2007
25 Supplement 2 p. 5882-5891
10 p.
artikel
176 The epidemiology and burden of rotavirus in China: A review of the literature from 1983 to 2005 Orenstein, Evan W.
2007
25 Supplement 2 p. 406-413
8 p.
artikel
177 The Meningitis Vaccine Project LaForce, F. Marc
2007
25 Supplement 2 p. A97-A100
nvt p.
artikel
178 The optimal interval for dendritic cell vaccination following adoptive T cell transfer is important for boosting potent anti-tumor immunity Park, Mi-Young
2007
25 Supplement 2 p. 7322-7330
9 p.
artikel
179 Therapeutic effect of hepatitis B surface antigen–antibody complex is associated with cytolytic and non-cytolytic immune responses in hepatitis B patients Yao, Xin
2007
25 Supplement 2 p. 1771-1779
9 p.
artikel
180 The requirement of CD80, CD86, and ICAM-1 on the ability of adjuvant formulations to potentiate antibody responses to a Plasmodium falciparum blood-stage vaccine Hui, George
2007
25 Supplement 2 p. 8549-8556
8 p.
artikel
181 The 23-valent pneumococcal polysaccharide vaccine does not provide additional serotype antibody protection in children who have been primed with two doses of heptavalent pneumococcal conjugate vaccine Balmer, Paul
2007
25 Supplement 2 p. 6321-6325
5 p.
artikel
182 TLR2 activation by proteosomes promotes uptake of particulate vaccines at mucosal surfaces Chabot, Sophie M.
2007
25 Supplement 2 p. 5348-5358
11 p.
artikel
183 TLR4-dependent adjuvant activity of Neisseria meningitidis lipid A Zughaier, Susu
2007
25 Supplement 2 p. 4401-4409
9 p.
artikel
184 Tumour immunity and T cell memory are induced by low dose inoculation with a non-replicating adenovirus encoding TAP1 Lou, Yuanmei
2007
25 Supplement 2 p. 2331-2339
9 p.
artikel
185 Typhoid fever vaccines: Systematic review and meta-analysis of randomised controlled trials Fraser, Abigail
2007
25 Supplement 2 p. 7848-7857
10 p.
artikel
186 Using pCIN-mIL-4 DNA vector to express mRNA and protein and to improve herpes simplex virus-induced Behcet's disease symptoms in mice Lee, Seung Ihm
2007
25 Supplement 2 p. 7047-7055
9 p.
artikel
187 Vaccination of cattle with TickGARD induces cross-reactive antibodies binding to conserved linear peptides of Bm86 homologues in Boophilus decoloratus Odongo, David
2007
25 Supplement 2 p. 1287-1296
10 p.
artikel
188 Vaccination of chickens against Campylobacter de Zoete, Marcel R.
2007
25 Supplement 2 p. 5548-5557
10 p.
artikel
189 Vaccination of horses against strangles using recombinant antigens from Streptococcus equi Waller, Andrew
2007
25 Supplement 2 p. 3629-3635
7 p.
artikel
190 Vaccination of sheep with Maedi-visna virus gag gene and protein, beneficial or harmful? Torsteinsdóttir, Sigurbjörg
2007
25 Supplement 2 p. 6713-6720
8 p.
artikel
191 Vaccination of white-tailed deer (Odocoileus virginianus) with Mycobacterium bovis bacillus Calmette Guerín Palmer, M.V.
2007
25 Supplement 2 p. 6589-6597
9 p.
artikel
192 Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice Delpino, Maria Victoria
2007
25 Supplement 2 p. 6721-6729
9 p.
artikel
193 WHO informal consultation on the scientific basis of specifications for production and control of inactivated Japanese encephalitis vaccines for human use, Geneva, Switzerland, 1–2 June 2006 Ferguson, Morag
2007
25 Supplement 2 p. 5233-5243
11 p.
artikel
194 WHO Working Group on standardisation and control of acellular pertussis vaccines—Report of a meeting held on 16–17 March 2006, St. Albans, United Kingdom Xing, D.K.L.
2007
25 Supplement 2 p. 2749-2757
9 p.
artikel
195 Widening inequalities in MMR vaccine uptake rates among ethnic groups in an urban area of the UK during a period of vaccine controversy (1994–2000) Hawker, Jeremy I.
2007
25 Supplement 2 p. 7516-7519
4 p.
artikel
                             195 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland